• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Experts Anticipate Second-generation Weight-loss Drugs

Video

Patients with obesity may require long-term pharmacologic management to sustain weight loss. Obesity expert Donna Ryan, MD, talks about new drugs in the pipeline.

Patients with obesity, like those with chronic illnesses such as hypertension, require long-term phamracologic treatment to maintain weight loss, according to Donna Ryan, MD, current president of the World Obesity Federation and associate editor of the journal Obesity. She notes in this short video that current weight-loss drugs help sustain reductions of approximately 10%. Agents in the pipeline may reliably increase that to 15%--a level where important metabolic change begins.

Dr Ryan is professor emerita at the Pennington Biomedical Research Center at Louisiana State University and well-known obeisty researcher.

She has been an investigator for various US National Institutes of Health-sponsored studies, including Pounds Lost, DASH (Dietary Approaches to Stop Hypertension), DPP (Diabetes Prevention Program) and the Look AHEAD study. Dr. Ryan’s continuing interests focus on translation of effective weight management into primary care practices.

Other Patient Care videos featuring Dr Ryan

Opening the Obesity Conversation in Primary Care

Weight Reduction Risk While Sheltering in Place

Obesity and COVID-19: Very Dangerous Together

Weight Loss is not about Achieving an "Ideal"

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Overweight and Obesity: One Expert's 3 Wishes for the Future of Patient Care
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
"Obesity is a Medically Approachable Problem" and Other Lessons with Lee Kaplan, MD, PhD
Related Content
© 2024 MJH Life Sciences

All rights reserved.